On shelf stability of freeze-dried: Poly(methylidene malonate 2.1.2) nanoparticles

International Journal of Pharmaceutics

Volumn 148, Issue 2, 1997, Pages 165-175

  Roy, D ^a   Guillon, X ^a   Lescure, F ^a   Couvreur, P ^b   Bru, N ^c   Breton, P ^a  

^a UPSA Laboratories   (France)

^b UNIV PARIS SUD   (France)

^c VIRSOL   (France)

Author keywords

Characterization; Colloid physicochemical; Freeze dried colloid stability; Methylidene malonate; Nanoparticles; Polymeric colloids

Indexed keywords

MALONIC ACID DERIVATIVE; NANOPARTICLE;

ARTICLE; COLLOID; CYTOTOXICITY; DRUG STABILITY; FREEZE DRYING; HUMAN; HUMAN CELL; ILLUMINATION; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STORAGE; T LYMPHOBLAST; TEMPERATURE; TURBIDITY;

EID: 0030937603     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04842-9     Document Type: Article

References (36)

1. Allémann, E., Gurny, R. and Doelker, E., Drug-loaded nanoparticles - Preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm., 39 (1993) 173-191.
2. Auvillain, M., Cavé, G., Fessi, H. and Devissaguet, J.P., Lyophilisation de vecteurs colloïdaux submicroniques. STP Pharma, 5 (1989) 738-744.
3. Birrenbach, G. and Speiser, P.P., Polymerized micelles and their use as adjuvants in immunology. J. Pharm. Sci., 65 (1976) 1763-1766.
4. Breton, P., Roy, D., Marchal-Heussler, L., Seguin, C, Couvreur, P. and Lescure, F., New poly(methylidene malonate 2.1.2) nanoparticles: recent developments. In Gregoriadis, G., McCormack, B. and Poste, G. (Eds), Targeting of Drugs, 4. Advances in System Constructs. NATO ASI series, Series A: Life Sciences, Vol. 273, Plenum Press, New York, 1994a, pp. 161-172.
5. Breton, P., Seguin, C., Roy, D., Couvreur, P. and Lescure, F., In vivo evaluation of poly(methylidene malonate 2.1.2) nanoparticle toxicity. Proc. Int. Symp. Control. Release Bioact. Mater., 21 (1994b) 608-609.
6. Breton, P., Guillon, X., Roy, D., Tamas, S., Marchal-Heussler, L., Bru, N. and Lescure, F., Evaluation of the interaction between poly(methylidene malonate 2.1.2) nanoparticles and an anti-CD4 by surface plasmon resonance (SPR). Eur. J. Pharm. Biopharm., 42 (1996) 95-103.
7. Bru-Magniez, N., De Cock, C., Poupaert, J., De Keyser, J.L. and Dumont, P., Procédé de préparation de monoesters ou diesters de l'acide endoéthano-9,10dihydro-9,10anthracène dicarboxylique-11,11, nouveaux monoesters ou diesters ainsi préparés et utilisation de ceux-ci pour la préparation de methylidène-malonates symétriques ou asymétriques. Eur. Patent EP 0 283 364 A2, 21 September, 1988.
8. Bru-Magniez, N., Chermann, J.C., Lescure, F., Teulon, J.M. and Breton, P., Immunoparticles bearing monoclonal antiCD4 antibodies and utilisation thereof. PCT World Patent WO 94/24168, 27 October, 1994.
9. Bru-Magniez, N., Chermann, J.C., Lescure, F., Teuton, J.M., Breton, P. and Guillon, X., Immunonanoparticles coated with anti-beta-2 microglobulin monoclonal antibodies. PCT World Patent WO 96/02278, 1 February, 1996.
10. Coffin, M.D. and McGinity, J.W., Biodegradable pseudolatexes: the chemical stability of poly(D,L-lactide) and poly(∈-caprolactone) nanoparticles in aqueous media. Pharm. Res., 9 (1992) 200-205.
11. Couvreur, P., Polyalkylcyanoacrylates as colloidal drug carriers. CRC Crit. Rev. Ther. Drug Carrier Syst., 5 (1988) 1-20.
12. Couvreur, P. and Vauthier, C., Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives. J. Control. Release. 17 (1991) 187-198.
13. Couvreur, P., Tulkens, P., Roland, M., Trouet, A. and Speiser, P., Nanocapsules: a new type of lysosomotropic carrier. FEBS Lett., 84 (1977) 323-326.
14. Couvreur, P., Kante, B., Roland, M., Guiot, P., Bauduin, P. and Speiser, P., Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol., 31 (1979) 331-332.
15. Denizot, F. and Lang, R., Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods, 89 (1986) 271-277.
16. Douglas, S.J., Davis, S.S. and Holding, S.R., Molecular weights of poly(buty12-cyanoacrylate) produced during nanoparticle formation. Br. Polym. J., 17 (1985) 339-342.
17. Fouarge, M., Dewulf, M., Couvreur, P., Roland. M. and Vranckx, H., Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis. J. Microencapsul., 6 (1989) 29-34.
18. Gaspar, R., Préat, V. and Roland, M., Nanoparticles of polyisohexylcyanoacrylate (PIHCA) as carriers of primaquine: formulation, physico-chemical characterization and acute toxicity. Int. J. Pharm., 68 (1991) 111-119.
19. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V. and Langer, R., Biodegradable long-circulating polymeric nanospheres. Science, 263 (1994) 1600-1603.
20. Gurny, R., Peppas, N.A., Harrington, D.D. and Banker, G.S., Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Dev. Ind. Pharm., 7 (1981) 1-25.
21. Gust, R., Bernhardt, G., Spruβ, T., Krauser, R., Koch, M., Schönenberger, H., Bauer, K.H., Schertl. S. and Lu, Z., Development of a parenterally administrable hydrosol preparation of the 'third generation platinum complex' [( ±)-1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II). Part 1. Preparation and studies on the stability and antitumor activity. Arch. Pharm., 328 (1995) 645-653.
22. Hanes, J., Chiba, M. and Langer, R., Polymer microspheres for vaccine delivery (Chpt. 16). In Powell, M.F. and Newman, M.J. (Eds.), Vaccine Design: the Subunit and Adjuvant Approach, Vol. 6. Plenum Press, New York, 1995, pp. 389-412.
23. Krause, H.J., Schwarz, A. and Rohdewald, P., Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs. Int. J. Pharm., 27 (1985) 145-155.
24. Kreuter, J., Poly(alkyl acrylate) nanoparticles. Methods Enzymol, 112 (1985) 129-138.
25. Kreuter, J. and Hartmann, H.R., Comparative study of the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180-bearing mice. Oncology, 40 (1983) 363-366.
26. Kreuter, J. and Speiser, P.P., In vitro studies of poly(methyl methacrylate) adjuvants. J. Pharm. Sci., 65 (1976) 1624-1627.
27. Kubiak, C., Manil, L. and Couvreur, P., Sorptive properties of antibodies onto cyanoacrylic nanoparticles. Int. J. Pharm., 41 (1988) 181-187.
28. Lescure, F., Zimmer, C., Roy, D., Teulon, J.M. and Couvreur, P., Synthesis and evaluation of a new biodegradable monomer. Proc. Int. Symp. Control. Release Bioact. Mater., 18 (1991) 325-326.
29. Lescure, F., Seguin, C., Breton, P., Bourrinet, P., Roy, D. and Couvreur, P., Preparation and characterization of novel poly(methylidene malonate 2.1.2.)-made nanoparticles. Pharm. Res., 11 (1994) 1270-1277.
30. Lherm, C., Müller, R.H., Puisieux, F. and Couvreur, P., Alkylcyanoacrylate drug carriers. II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int. J. Pharm., 84 (1992) 13-22.
31. Magenheim, B. and Benita, S., Nanoparticle characterization: a comprehensive physicochemical approach. STP Pharm. Sci., 1 (1991) 221-241.
32. Manil, L., Roblot-Treupel, L. and Couvreur, P., Isobutyl cyanoacrylate nanoparticles as a solid phase for an efficient immunoradiometric assay. Biomaterials, 7 (1986) 212-216.
33. Müller, R.H., Mehnert, W., Lucks, J.S., Schwarz. C., zur Mühlen, A., Weyhers, H., Freitas, C. and Rühl, D., Solid lipid nanoparticles (SLN) - An alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm., 41 (1995) 62-69.
34. Rolland, A., Gibassier, D., Sado, P. and Le Verge, R., Méthodologie de préparation de vecteurs nanoparticulaires à base de polymères acryliques. J. Pharm. Belg., 41 (1986) 83-93.
35. Seijo, B., Fattal, E., Roblot-Treupel, L. and Couvreur, P., Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. Int. J. Pharm., 62 (1990) 1-7.
36. Velge-Roussel, F., Breton, P., Guillon, X., Lescure, F., Bru, N., Bout, D. and Hoebeke, J., Immunochemical characterization of antibody-coated nanoparticles. Experientia, 52 (1996) 803-806.